About Kaiser Permanente Vaccine Study Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
3
Pfizer
3
MassBiologics
1
MedImmune LLC
1
Novartis Vaccines
1
Protein Sciences Corporation
1
Clinical Trials at Kaiser Permanente Vaccine Study Center
During the past decade, Kaiser Permanente Vaccine Study Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT
2002-05-01
2002-08-01
Completed
330
Expanded Dryvax Dilution Study in Previously Vaccinated Adults
2002-10-01
2003-12-01
Completed
927
Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age
2004-10-01
2005-12-01
Completed
8,500
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children
2005-04-01
2006-11-01
Completed
910
Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease
2006-07-20
2008-06-25
Completed
200
Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease
2010-07-01
2015-04-01
Completed
1
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
2011-03-01
2014-03-01
Completed
1,384
Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.
2014-09-01
2015-05-01
Completed
882
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kaiser Permanente Vaccine Study Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials, followed by "Pfizer" with 3 trials
sponsored, "MassBiologics" with 1 trials sponsored, "MedImmune LLC" with 1 trials sponsored and "Novartis Vaccines"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Vaccine Study Center"
#1 collaborator was "Kaiser Permanente" with 2 trials as a collaborator and "Medarex" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Kaiser Permanente Vaccine Study Center
According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Vaccine Study Center" are
"Smallpox" (2 trials), "Clostridium Infections" (1 trials), "Human Influenza" (1 trials), "Influenza" (1 trials) and "Invasive Pneumococcal Disease" (1 trials). Many other conditions were trialed in "Kaiser Permanente Vaccine Study Center" in a lesser frequency.
Clinical Trials Intervention Types at Kaiser Permanente Vaccine Study Center
Most popular intervention types in "Kaiser Permanente Vaccine Study Center" are "Biological" (8 trials), "Other" (3 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "GS-CDA1/MDX-1388" (1 trials), "Inactivated Influenza Vaccine" (1 trials) and "Liquid CAIV-T" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kaiser Permanente Vaccine Study Center
The vast majority of trials in "Kaiser Permanente Vaccine Study Center" are
10 trials for "All" genders.
Clinical Trials Status at Kaiser Permanente Vaccine Study Center
Currently, there are NaN active trials in "Kaiser Permanente Vaccine Study Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Kaiser Permanente Vaccine Study Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kaiser Permanente Vaccine Study Center, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".